When compared with PLWH commencing ART with CD4 cell counts below 100 cells/mm3, those with CD4 cell counts between 100 and 199 had a 51% lower risk (aHR 0.49, 95% CI 0.27–0.88) while those with CD4 cell counts ≥200 cells/mm3 had a 58% lower risk of developing cancer (aHR 0.42, 95% CI 0.23–0.77), see Table 2. Here, CD4 is linked to cancer.